GW PHARMACEUTICALS
GW is a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, EPIDIOLEX (cannabidiol) oral solution, is commercialized in the U.S. by its U.S. subsidiary Greenwich Biosciences for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome, or tuberous sclerosis complex (TSC) in patients one year of age and ol... der. This product has received approval in the European Union under the tradename EPIDYOLEX for the adjunctive treatment of seizures associated with LGS or Dravet syndrome in conjunction with clobazam in patients two years and older and is under EMA review for the treatment of TSC. The Company has a deep pipeline of additional cannabinoid product candidates, in particular nabiximols, for which the Company is advancing multiple late-stage clinical programs in order to seek FDA approval in the treatment of spasticity associated with multiple sclerosis and spinal cord injury. The Company has additional cannabinoid product candidates in clinical trials for autism and schizophrenia.
GW PHARMACEUTICALS
Industry:
Biotechnology Cannabis Health Care Pharmaceutical Therapeutics
Founded:
1998-01-01
Address:
Histon, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.gwpharm.com
Total Employee:
501+
Status:
Active
Contact:
+44 (0) 1223 238170
Total Funding:
1.22 B USD
Technology used in webpage:
SPF LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Domain Not Resolving Euro Microsoft Exchange Online Amazon IPv6 JsDelivr
Similar Organizations
2A Pharma
2A Pharma is a biopharmaceutical company focused on discovering, developing and commercialising novel, cost effective vaccines.
CANbridge Pharmaceuticals
CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare .
CannAssist International
CannAssist International is a researched-based company focused on creating higher-level alternative therapeutics.
Crinetics Pharmaceuticals
Crinetics is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics.
Kalapa Clinic
Kalapa Clinic is a medical consultancy pioneered for alternative therapies using cannabinoids.
Keros Therapeutics
Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.
Scilex Pharmaceuticals
Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products.
Current Advisors List
Board_member
Board_member
Board_member
2020-01-01
Current Employees Featured
Tina St Leger Chief Human Resources Officer @ GW Pharmaceuticals
Chief Human Resources Officer
2019-07-01
Scott Giacobello Chief Financial Officer @ GW Pharmaceuticals
Chief Financial Officer
2017-03-01
Volker Knappertz Chief Medical Officer @ GW Pharmaceuticals
Chief Medical Officer
2017-05-01
Adam George UK Managing Director @ GW Pharmaceuticals
UK Managing Director
2017-03-01
Krisztian Kenderesi Associate Director (Deputy Head) of Information Security @ GW Pharmaceuticals
Associate Director (Deputy Head) of Information Security
2020-06-01
Douglas Snyder Chief Legal Officer @ GW Pharmaceuticals
Chief Legal Officer
2017-09-01
Geoffrey Guy Founder @ GW Pharmaceuticals
Founder
1998-01-01
Julian Gangolli President of North America @ GW Pharmaceuticals
President of North America
2015-05-01
Founder
Stock Details
Investors List
Mentor Capital
Mentor Capital investment in Post-IPO Equity - GW Pharmaceuticals
Official Site Inspections
http://www.gwpharm.com
- Host name: ec2-52-88-89-3.us-west-2.compute.amazonaws.com
- IP address: 52.88.89.3
- Location: Boardman United States
- Latitude: 45.8491
- Longitude: -119.7143
- Metro Code: 810
- Timezone: America/Los_Angeles
- Postal: 97818
More informations about "GW Pharmaceuticals"
GW Pharmaceuticals - Wikipedia
GW Pharmaceuticals was founded in 1998 by doctors Geoffrey Guy and Brian Whittle. That year, they obtained a cultivation license from the United Kingdom Home Office and the MHRA, allowing the company to cultivate, possess and supply cannabis to conduct scientific research concerning medical cannabis. Later in 1998, GW Pharmaceuticals entered into a contract with Hortapharm B.V., a cannabis re…See details»
Jazz Pharmaceuticals Completes Acquisition of GW …
May 5, 2021 The Company plans to provide 2021 financial guidance for the combined Jazz/GW organization within the next 45 days. Under the terms of the agreement, holders of GW ADSs, …See details»
Jazz to Acquire GW Pharmaceuticals
Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating …
DUBLIN and LONDON, Feb. 3, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and GW Pharmaceuticals plc (Nasdaq: GWPH) today announced the companies have entered …See details»
Jazz Pharmaceuticals Completes Acquisition of GW …
May 5, 2021 The Company plans to provide 2021 financial guidance for the combined Jazz/GW organization within the next 45 days. Under the terms of the agreement, holders of GW ADSs, ...See details»
GW Pharmaceuticals Company Profile 2024: Valuation, Investors ...
Information on acquisition, funding, investors, and executives for GW Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
GW Pharmaceuticals Ltd - Company Profile - GlobalData
GW Pharmaceuticals Plc (GW Pharmaceuticals), a subsidiary of Jazz Pharmaceuticals, is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics …See details»
GW Pharmaceuticals plc - LinkedIn
Sovereign House, Vision Park Chivers Way, Histon Cambridge, CB24 9BZ, GBSee details»
GW Pharmaceuticals - Overview, News & Similar companies
Jan 31, 2023 GW Pharmaceuticals contact info: Phone number: +44 1223266800 Website: www.gwpharm.co.uk What does GW Pharmaceuticals do? GW Pharmaceuticals' vision is to …See details»
GW Pharmaceuticals - Craft
Global Legal Cannabis Market Report 2022-2030 Featuring Gw Pharmaceuticals, Aurora, Aphria, Cronos, Tilray, Sundial Growers, Insys Therapeutics, Scotts Co, Vivo Cannabis, & Cara …See details»
GW Pharmaceuticals Shareholders Approve Acquisition by Jazz …
Apr 23, 2021 For more information, please visit www.jazzpharmaceuticals.com. GW Pharmaceuticals Media Contacts: US: Kristen Cardillo, Vice President, Corporate …See details»
GW Pharmaceuticals Shareholders Approve Acquisition by Jazz
Apr 23, 2021 GW Pharmaceuticals Media Contacts: US: Kristen Cardillo, Vice President, Corporate Communication kcardillo@gwpharm.com +1 760 579 6628 UK : Ben Atwell , FTI …See details»
Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating …
Feb 3, 2021 Copies of the documents filed with the SEC by GW Pharmaceuticals will be available free of charge on GW Pharmaceuticals' website at https://www.gwpharm.com. …See details»
GW Pharmaceuticals plc Reports Fourth Quarter and Year-End
Feb 16, 2021 Investors: Scott Giacobello, Chief Financial Officer: 760 795 2200 / sgiacobello@gwpharm.com Media: Kristen Cardillo, VP, Corporate Communications: …See details»
Improving Patients' Lives | Jazz Pharmaceuticals
Nov 20, 2024 Organization: Address Line 1: Address Line 2: City: State: Zip Code: Country: Phone Number: Email Address: First Name: Therapeutic Area: Indication: Mechanism of …See details»
GW Pharmaceuticals plc Reports Fourth Quarter and Year-End …
Feb 16, 2021 Enquiries: Investors: Scott Giacobello, Chief Financial Officer760 795 2200 / sgiacobello@gwpharm.com Media: Kristen Cardillo, VP, Corporate …See details»
GW Pharmaceuticals Provides Preliminary Fourth Quarter and
Jan 11, 2021 GW Pharmaceuticals plc Scott Giacobello, Chief Financial Officer: 760 795 2200: U.S. Media Christy Curran Sam Brown Inc. Healthcare CommunicationsSee details»
GW Pharmaceuticals Shareholders Approve Acquisition by Jazz
Apr 23, 2021 sgiacobello@gwpharm.com +1 (760) 795 2200. Jazz Pharmaceuticals Media Contact: Jacqueline Kirby, Vice President, Corporate Affairs & Government Relations Ireland …See details»
GW Pharmaceuticals Achieves Positive Results in Phase 2 Proof of ...
The Company has a deep pipeline of additional cannabinoid product candidates which includes compounds in Phase 1 and 2 trials for glioma, schizophrenia and epilepsy. For further …See details»